{"timestamp": 1771602812.4127667, "value": {"ticker": "PYXS", "company_name": "Pyxis Oncology, Inc.", "short_name": "Pyxis Oncology, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 91528400, "float_shares": 40115588, "shares_outstanding": 62264215, "short_ratio": 1.77, "short_percent_of_float": 0.0463, "shares_short": 2386094, "shares_short_prior": 1733403, "insider_percent_held": 0.22662, "institution_percent_held": 0.37892, "total_cash": 76256000, "total_debt": 19073000, "total_revenue": 2820000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -29.30248, "debt_to_equity": 27.731, "current_ratio": 4.286, "book_value": 1.107, "price_to_book": 1.3279133, "operating_cashflow": -72365000, "free_cashflow": -40940624, "price": 1.47, "52w_high": 5.55, "52w_low": 0.833, "avg_volume": 1269961, "avg_volume_10d": 653150, "full_time_employees": 44, "audit_risk": 0, "overall_risk": 0}}